Delivery Order SPE2DB20D3103-SPE2DB23FN2V6

Award Date 5/3/23
Potential Completion Date 5/4/23
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal XR 200 mg tablets. The $61,463.45 firm fixed price contract has a period of performance through July 29, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and medical products to support military...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order contract with a ceiling value of $19,863.24. The contract is for the provision of LAMICTAL XR 25 MG TABLET 30S and is issued by the Defense Logistics Agency (DLA). The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and veterans'...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal 200 mg tablets. The $5,161.59 firm fixed-price contract has a completion date of July 20, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LAMICTAL XR 25 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price ceiling value of $3,826.35 and an ultimate completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside for any small business category. The contract is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,705.76 Firm Fixed Price contract is for the supply of LAMICTAL XR 100 MG TABLET 30S, a medication used to treat certain types of seizures. The contract has a period of performance through February 5, 2025 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $4,268.57 for the supply of LAMICTAL XR 200 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This award is placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Lamictal XR 100 mg tablets. The contract has a ceiling value of $8,517.56 and is a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,278.44 Firm Fixed Price Delivery Order is for the supply of 4558164029 LAMICTAL XR 50 MG TABLET 30S, with an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This contract award, SPE2DB20D3103|SPE2DB24FP2Q9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.24 firm fixed price delivery order is for the supply of LAMICTAL 200 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $11,433.96 firm-fixed-price delivery order is for the supply of 4565179509 - LAMICTAL XR 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FN2V6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of LAMICTAL XR 200 MG TABLET 30S. The contract has a total ceiling value of $8,611.21 and an ultimate completion date of May 4, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 9:52 AM